Strategic Partnerships QSA Global actively engages in multi-year partnerships across the radiation source and nuclear technology ecosystem, including recent collaborations with NorthStar for actinium-225 supply chain and Perpetual Atomics for americium processing. Sales opportunities exist in expanding supply agreements, logistics partnerships, and co-developed solutions for targeted therapies and space nuclear tech.

Expansion in Targeted Therapies The company’s role in supplying sources used for medical research and targeted alpha therapies positions it to capitalize on growing demand for radiopharmaceuticals and associated turnkey services. Explore partnerships with biotech and pharmaceutical firms requiring reliable sealed sources and compliant packaging for clinical and production workflows.

Diverse Application Footprint QSA Global serves multiple high-use sectors—oil well logging, non-destructive testing, X-ray imaging, and reactor startup—indicating broad cross-sell potential to customers seeking single-vendor radiation source solutions, quality control, and safety-compliant logistics across industries.

Global Logistics and Compliance With a global export network and stringent USNRC-compliant quality controls, there is a sales emphasis on geographic expansion and compliance-driven logistics services. Opportunities exist to offer end-to-end distribution, regulatory consulting, and risk-managed transportation for sensitive sources.

Financial Scale and Growth Revenue in the range of $100M-$250M and a long-standing industry presence suggest capacity for larger, multi-year contracts and service-driven ARR models. Focus on securing strategic supply agreements, maintenance and calibration services, and bundled technology offerings to deepen wallet share with existing customers.